Daun Penh Cambodia Group and Sistema Asia Fund were among the investors in a $35m series C round for online pharmacy NetMeds.

GV has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford whose existing shareholders include Oxford Sciences Innovation.

Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.

Almi Invest and trade union Unionen have both returned with funding for Beactica, a drug discovery company based on Uppsala University research.

A month after Sutro closed an $85.4m series E round, the cancer drug developer, based on research at Stanford, has filed for a $75m initial public offering.

A month after Sutro closed an $85.4m series E round backed by Merck & Co, Celgene, Amgen and Eli Lilly, the cancer drug developer has filed for a $75m initial public offering.

Epigenomics services provider Epinomics, co-founded by Stanford University faculty and alumni, has been bought by 10x Genomics in a transaction which enables StartX to exit.

Vertex Pharmaceuticals has led a series B round for Genomics, a spinout from University of Oxford that also attracted Oxford Sciences Innovation and IP Group.

Vertex Pharmaceuticals has led a series B round for Genomics, a spinout from University of Oxford that also attracted Oxford Sciences Innovation and IP Group.